<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
85822-734-15
</NDCCode>
<PackageDescription>
15 g in 1 TUBE (85822-734-15)
</PackageDescription>
<NDC11Code>
85822-0734-15
</NDC11Code>
<ProductNDC>
85822-734
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Regranex Gel 0.01%
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Becaplermin Gel 0.01%
</NonProprietaryName>
<DosageFormName>
GEL
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20250613
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA103691
</ApplicationNumber>
<LabelerName>
Lynch Regnerative Medicine
</LabelerName>
<SubstanceName>
BECAPLERMIN
</SubstanceName>
<StrengthNumber>
.1
</StrengthNumber>
<StrengthUnit>
mg/g
</StrengthUnit>
<Pharm_Classes>
Human Platelet-derived Growth Factor [EPC], Platelet-Derived Growth Factor [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-11-07
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250630
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>